OROJIN Launches at BIOHK 2025, Promising AI Biomarker Revolution
September 15, 2025 | 14:46
Five millilitre blood sample predicts illness five years ahead, giving clinicians fresh SEO fodder around preventive medicine and Hong Kong biotech breakthroughs.
BeOne Medicines Wins BIOHK 2025 Oncology Award for “1+” Cancer Platform
September 11, 2025 | 09:50
Breakthrough “1+” model fast-tracks combo trials, cutting IND-to-Phase-I time 40 per cent and bagging the Global Oncology Innovation Leadership prize.
Mobile Version